Results 121 to 130 of about 7,687,257 (287)

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito   +8 more
wiley   +1 more source

Pulse oximetry screening for clinically unrecognized critical congenital heart disease in the newborns [PDF]

open access: yes, 2007
The aim of this article is to determine the incidence of clinically unrecognized critical congenital heart disease (CCHD) in the newborns by using pulse oximetric screening.peer ...
Pongpanich, Boonchab   +2 more
core  

Clinical characteristics and epidemiological analysis of 23 cases of tick-borne rickettsiosis in Xinjiang Uygur Autonomous Region

open access: yesFrontiers in Cellular and Infection Microbiology
BackgroundPreviously, at least ten spotted fever group Rickettsia (SFGR) species were detected in wildlife and hard ticks in Xinjiang Uygur Autonomous Region (XUAR, northwestern China), whereas human infection remains scarcely studied.MethodsDuring April
Minghui Yun   +19 more
doaj   +1 more source

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand   +5 more
wiley   +1 more source

Metastatic Female Breast Cancer Incidence [PDF]

open access: yes
From 2001 to 2021, a total of 4,652,885 new cases of female breast cancer were reported in the United States. Of these, 260,379 (5.6%) were distant stage (metastatic) at diagnosis. The incidence of metastatic female breast cancer increased from 2001 (5.8

core  

Seedbed inspections underestimate the overall incidence of ratoon stunting disease

open access: yes, 2016
In Australia, only prospective seedbeds are routinely screened for ratoon stunting disease (RSD). As seedbeds may reasonably be considered to be the healthiest cane available to a grower, it may be expected that there would be a higher incidence of RSD ...
Young, Anthony
core   +1 more source

Integrating Time‐Adjusted Imaging Instability Into Functional Outcome Prediction After Intracerebral Hemorrhage: Development and Validation of the HAGIV Score

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Early risk stratification may support clinical decision‐making in spontaneous intracerebral hemorrhage (ICH). We aimed to develop and internally validate HAGIV, a score integrating frequency of imaging markers (FIM), a time‐adjusted non‐contrast computed tomography (CT) metric of hematoma expansion, with established predictors for 90‐
Lei Song   +10 more
wiley   +1 more source

Highlights from 2021 Cancer Incidence with Comparisons to Previous Years [PDF]

open access: yes
U.S. Cancer Statistics includes 1,777,566 new cases of invasive cancer occurring in 2021.Each year, the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI) produce updated U.S. Cancer Statistics data.

core  

The Multiple Sclerosis Severity Allele rs10191329A and Cognitive Function: A UK Biobank Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The genome‐wide association study of Multiple Sclerosis severity linked the genetic variant rs10191329A to long‐term disability and implicated brain resilience as a determinant of outcome. We hypothesised that rs10191329A might influence cognition in other neurological diseases and healthy controls.
Ioanna Zimianiti   +5 more
wiley   +1 more source

Clinical and Modifiable Factors Associated With Disability and Relapse in MOGAD: A Multicentre Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Factors associated with relapse course and disability in myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) remain incompletely understood. Objectives To identify clinical and modifiable factors associated with relapse and disability in MOGAD. Methods In this ambispective multicentre cohort study using data from
Yingtao Wang   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy